Fda | The Truth About Skin Care

{ Tag Archives } Fda

Great Strategies About Cosmetic Science And The Exceptional Eyelash Enhancer

Is there a method that has been proven to grow longer eyelashes? If there was would you like to be able to grow your eyelashes to be thicker, longer, and have more density? In response to medical research and exams there’s a product, it is known as an eyelash enhancer. It’s confirmed to be able [...]

Also tagged Beautiful, Beauty, Beauty article, beauty guide, beauty information, Beauty Tips, Cosmetic Science, Curlers, Density, Different Products, Eyelash, Forefront, Girls, Hype, Longer Eyelashes, Mascara, Medical Exams, Medical Research, Period Of Time, Proof, Proud Member, Stunning Results

2010 09 02 Skin Care News Comments (0)

An Honest Look At Idol Lash For Eyelash Growth

I must admit I was pretty excited when Idol Lash was released onto the market. It wasn’t until earlier this year that I learned there were products that could actually help you grow your eyelashes and eyebrows, leading to longer, thicker, and even darker brows and lashes, which is great for someone who’s been dyeing [...]

Also tagged Brows, Dyeing, Eyebrow Pencil, Eyebrows, Eyelashes, Free Trial, Free Trials, idol lash, idol lash review, Idol Lash reviews, Lash, Lashes, Little Bit, Makeup, Mascara, Money, Offline World, Pharmaceutical Products, Reason

2010 09 01 Skin Care News Comments (0)

Cellceutix Corporation Selects Destum Partners To Partner Psoriasis Compound

Main Category: Eczema / Psoriasis
Also Included In: Dermatology
Article Date: 26 Jul 2010 – 5:00 PDT

email to a friend printer friendly view / write opinions
<!– rate article

Cellceutix Corporation (OTCBB: CTIX) is pleased to announce that it has selected Destum Partners to assist in finding a development partner for its [...]

Also tagged Animal Model, Autism, Compound Annual Growth Rate, Consequence, Ctix, Development Partner, Eczema, Fda Approval Process, Friendly View, George Evans, Lt, Methotrexate, Otcbb, Pipeline, Potential Partners, Psoriasis, Rate Article, Shareholder Value, Xenograft

2010 07 26 Skin Care News Comments Off

So You Want To Learn About TCA Peels?

You may or might not be familiar with simple chemical peels, especially the TCA peel.
What are they? In an exceedingly nutshell a chemical peel could be a controlled chemical that is place on your skin and will result in the breakage of the deep cell bonds to the outermost layers of your skin. If [...]

Also tagged Acne, Blue Dyes, Bonds, Chemical Peel, Chemicals, Creamy Mixture, Crows Feet, Different Kinds, Layers Of The Skin, New Skin, Nutshell, Obagi Blue Peel, Outermost Layers, Peeling, Probability, Skin Pigmentation, Superficial Layers, Tca chemical peel, Tca Peel, TCA Peels, tca skin peel, Wrinkles

2010 06 11 Skin Care News Comments (0)

NexMed To Discuss P2/3 Protocol For NexACT(R)-Based Alprostadil Treatment For Raynaud’s Syndrome With The FDA

NexMed, Inc. (Nasdaq: NEXM), a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the U.S. Food & Drug Administration (FDA) has granted the Company an Investigational New Drug application number for its NexACT-based alprostadil treatment for Raynaud’s syndrome, ahead of a pre-IND meeting in mid-July 2010 to discuss [...]

Also tagged Ahead, Amp, Application Number, Cro, Drug Administration, Drug Application, Nasdaq, Nexmed Inc, Phase 2, Pipeline, Protocol, Raynaud S Syndrome, Today Announced That

2010 05 19 Skin Care News Comments Off

FDA: Serious Side Effects From Swallowing Topical Benadryl Product

The U.S. Food and Drug Administration is warning consumers about potentially serious side effects from mistakenly swallowing Benadryl Extra Strength Itch Stopping Gel, an over-the-counter (OTC) product that should only be used on the skin. The FDA has received reports of serious side effects in people who have mistakenly swallowed the product…

Also tagged Benadryl, Consumers, Extra Strength, Food And Drug, Food And Drug Administration, Otc Product, People

2010 05 13 Skin Care News Comments Off

Expert Available For Comment: CMS To Cover Injections For HIV-Associated Facial Lipoatrophy

In a landmark decision, the Centers for Medicare & Medicaid Services (CMS) has announced it will now cover the use of FDA-approved dermal fillers for the treatment of HIV-associated facial lipoatrophy (LA), severely hollowed cheeks and changes to the face’s appearance resulting from HIV treatments…

Also tagged Amp, Appearance, Cheeks, Cms, Expert, Face, Facial, Fillers, Hiv, Hiv Treatments, Landmark Decision, Lipoatrophy, Medicaid, Medicaid Services, Medicare, Medicare Medicaid, Treatment Of Hiv

2010 03 30 Skin Care News Comments Off

FDA Considers Tightening Restrictions On Tanning Beds

The Food and Drug Administration may tighten restrictions on tanning beds “amid evidence they raise the risk of skin cancer beyond exposure to ultraviolet radiation from the sun,” The Wall Street Journal reports. “Because tanning beds aren’t considered medical devices, the FDA can only regulate the emissions from the lamps used in the beds…

Also tagged Emissions, Food And Drug, Food And Drug Administration, Lamps, Medical Devices, Risk, Skin Cancer, Sun, Tanning Beds, Ultraviolet Radiation, Wall Street, Wall Street Journal

2010 03 29 Skin Care News Comments Off

American Academy Of Dermatology Association Testifies At FDA Hearing On Indoor Tanning Devices

American Academy of Dermatology Association (AADA) President and dermatologist William D. James, MD, FAAD, along with other dermatologists and leading researchers today testified before a Food and Drug Administration (FDA) panel considering changes to the current classification of indoor tanning devices…

Also tagged Aada, Academy Of Dermatology, American Academy Of Dermatology, American President, Current, Dermatologist, Dermatologists, Dermatology Association, Fda Panel, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Hearing Devices, Indoor Tanning, Tanning Devices, William D James, William D James Md

2010 03 26 Skin Care News Comments Off

Galderma Received FDA Approval Of Differin(R) (adapalene) Lotion, 0.1%, The First Retinoid Available In Lotion Formulation

Galderma Laboratories, L.P. announced the U.S. Food and Drug Administration (FDA) approval of Differin® (adapalene) Lotion, 0.1%, the first-ever lotion formulation of the well-tolerated retinoid adapalene, for the treatment of acne. Differin Lotion, 0.1% will be available by prescription in April 2010. Differin Lotion, 0…

Also tagged Acne, Adapalene, April, Differin, Fda Approval, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Retinoid, Treatment Of Acne

2010 03 23 Skin Care News Comments Off

The Truth About Skin Care

{ Tag Archives } Fda

Great Strategies About Cosmetic Science And The Exceptional Eyelash Enhancer

An Honest Look At Idol Lash For Eyelash Growth

Cellceutix Corporation Selects Destum Partners To Partner Psoriasis Compound

So You Want To Learn About TCA Peels?

NexMed To Discuss P2/3 Protocol For NexACT(R)-Based Alprostadil Treatment For Raynaud’s Syndrome With The FDA

FDA: Serious Side Effects From Swallowing Topical Benadryl Product

Expert Available For Comment: CMS To Cover Injections For HIV-Associated Facial Lipoatrophy

FDA Considers Tightening Restrictions On Tanning Beds

American Academy Of Dermatology Association Testifies At FDA Hearing On Indoor Tanning Devices

Galderma Received FDA Approval Of Differin(R) (adapalene) Lotion, 0.1%, The First Retinoid Available In Lotion Formulation

Home

Recommendations

Free Ebook

Latest News

Site Features

Get a free ebook valued at $8.95 when you sign up for our free Skincare Tips newsletter. The book The Truth About Skincare: How To Have Younger Looking Skin sells every day for $8.95 at Bargain Books Web. It's yours at no cost by immediate download when you sign up right now. You can unsubscribe any time, and the book is yours to keep.
Name:
Email: